Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$853,047,884
+$59,359,089 QoQ
Shares Held
2,355,705
+4.4% QoQ
Ownership
0.436%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#31
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Mar 31, 2020CallValue
$9,731
CallShares
48
PutValue
$11,961
PutShares
59
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $18,000,750,668 across 17 Drug Manufacturers - General names. AMGN ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,379,627 | $4,053,626,340 | |
| 2 | JNJ |
Johnson & Johnson
|
15,661,323 | $3,977,506,192 | |
| 3 | ABBV |
AbbVie Inc.
|
10,772,949 | $2,710,904,874 | |
| 4 | AZN |
Astrazeneca PLC
|
12,640,672 | $2,396,924,218 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,964,180 | $1,537,397,125 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,269,170 | $918,386,928 | |
| 7 | AMGN |
Amgen Inc
This page
|
2,355,705 | $853,047,884 | |
| 8 | PFE |
Pfizer Inc
|
31,492,018 | $758,327,787 |
All Filings in AMGN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $853,047,884 | 2,355,705 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $793,688,795 | 2,255,759 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $717,073,682 | 2,190,809 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $744,508,497 | 2,638,230 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $705,901,502 | 2,528,210 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,017,525,093 | 3,266,009 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $837,507,988 | 3,213,275 | Shares | Sole | 2025-06-30 | |
| 2024-09-30 | $1,032,532,568 | 3,204,533 | Shares | Sole | 2025-06-26 | |
| 2024-06-30 | $1,035,292,757 | 3,313,467 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $926,778,278 | 3,259,631 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $800,132,225 | 2,778,044 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $758,225,702 | 2,821,200 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $742,632,690 | 3,344,891 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $816,734,961 | 3,378,428 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $832,634,977 | 3,170,252 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,109,417,664 | 4,921,995 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,180,353,639 | 4,851,433 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,262,362,540 | 5,220,257 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,273,379,231 | 5,660,218 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,107,155,411 | 5,206,468 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,194,267,498 | 4,899,559 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,122,775,765 | 4,512,583 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $967,238,483 | 4,206,848 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $906,850,747 | 3,568,031 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $879,804,018 | 3,730,196 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $11,961 | 59 | Put | Defined | 2020-05-14 | |
| 2020-03-31 | $9,731 | 48 | Call | Defined | 2020-05-14 | |
| 2020-03-31 | $805,134,685 | 3,971,463 | Shares | Other | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||